Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation:: Effect on hormonal levels and follicular development in in vitro fertilization cycles

被引:46
作者
Kolibianakis, EM [1 ]
Albano, C [1 ]
Camus, M [1 ]
Tournaye, H [1 ]
Van Steirteghem, AC [1 ]
Devroey, P [1 ]
机构
[1] Dutch Speaking Brussels Free Univ, Ctr Reprod Med, B-1090 Brussels, Belgium
关键词
D O I
10.1210/jc.2003-030805
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of the present study was to assess the effect of altering the timing of GnRH antagonist initiation on the hormonal environment and follicular development in in vitro fertilization cycles. Sixty women undergoing in vitro fertilization participated in a prospective randomized controlled trial. Patients were stimulated with a fixed dose of 200 IU recombinant FSH, starting on d 2 of the cycle, and with GnRH antagonist, starting either on d 1 (n = 30) or on d 6 of stimulation (n = 30). A significantly lower exposure to LH (P< 0.001) and estradiol ( P < 0.001) during the follicular phase was observed in the d-1 group, compared with the d-6 group of antagonist administration. No differences in follicular development were seen between the two groups on either d 6 of stimulation or on the day of human chorionic gonadotropin administration. Similar fertilization rates, implantation rates, and ongoing pregnancy rates per transfer were, in addition, present between the two groups compared. In conclusion, administration of GnRH antagonist on d 1 ( compared with d 6) of stimulation is associated with a lower exposure to LH and estradiol, which does not seem to affect follicular development.
引用
收藏
页码:5632 / 5637
页数:6
相关论文
共 26 条
[1]  
Al-Inany H, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001750, DOI 10.1002/14651858.CD001750, 10.1002/14651858.Cd001750]
[2]   Ovarian stimulation with HMG:: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin [J].
Albano, C ;
Felberbaum, RE ;
Smitz, J ;
Riethmüller-Winzen, H ;
Engel, J ;
Diedrich, K ;
Devroey, P .
HUMAN REPRODUCTION, 2000, 15 (03) :526-531
[3]  
Albano C, 1996, HUM REPROD, V11, P2114
[4]  
[Anonymous], 1998, J Clin Endocrinol Metab, V83, P1507
[5]   Ovarian response to recombinant human follicle-stimulating hormone in luteinizing hormone-depleted women: Examination of the two cell, two gonadotropin theory [J].
BenChetrit, A ;
Gotlieb, L ;
Wong, PY ;
Casper, RF .
FERTILITY AND STERILITY, 1996, 65 (04) :711-717
[6]  
Borm G, 2000, HUM REPROD, V15, P1490
[7]   SUPPRESSION OF THE ENDOGENOUS LUTEINIZING-HORMONE SURGE BY THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST CETRORELIX DURING OVARIAN STIMULATION [J].
DIEDRICH, K ;
DIEDRICH, C ;
SANTOS, E ;
ZOLL, C ;
ALHASANI, S ;
REISSMANN, T ;
KREBS, D ;
KLINGMULLER, D .
HUMAN REPRODUCTION, 1994, 9 (05) :788-791
[8]   The role of estrogen in folliculogenesis [J].
Drummond, AE ;
Findlay, JK .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 151 (1-2) :57-64
[9]   Concurrent ganirelix and follitropin beta therapy is an effective and safe regimen for ovulation induction in women with polycystic ovary syndrome [J].
Elkind-Hirsch, KE ;
Webster, BW ;
Brown, CP ;
Vernon, MW .
FERTILITY AND STERILITY, 2003, 79 (03) :603-607
[10]   FSH INDUCTION OF FUNCTIONAL LH RECEPTORS IN GRANULOSA-CELLS CULTURED IN A CHEMICALLY DEFINED MEDIUM [J].
ERICKSON, GF ;
WANG, C ;
HSUEH, AJW .
NATURE, 1979, 279 (5711) :336-338